Based on the SMILES CC1(C)CCN1c1nc(N)nc2c1ncn2[C@H]1C=C[C@@H](CO)C1, the molecule can be described as:
The molecule is a 2,6-diaminopurine that is an analogue of abacavir in which the cyclopropylamino group at position 6 of the purine moiety is replaced by a 2,2-dimethylazetidin-1-yl group. One of a series of synthesised abacavir analogues with antiviral activity found to stimulate IFN-gamma secretion in abacavir-responsive clones. It has a role as an antiviral agent. It derives from an abacavir.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule can be described {#by|as!}:
{description#}
CC1(C)CCN1c1nc(N)nc2c1ncn2[C@H]1C=C[C@@H](CO)C1
[(1S,4R)-4-[2-amino-6-(2,2-dimethylazetidin-1-yl)purin-9-yl]cyclopent-2-en-1-yl]methanol
The molecule is a 2,6-diaminopurine that is an analogue of abacavir in which the cyclopropylamino group at position 6 of the purine moiety is replaced by a 2,2-dimethylazetidin-1-yl group. One of a series of synthesised abacavir analogues with antiviral activity found to stimulate IFN-gamma secretion in abacavir-responsive clones. It has a role as an antiviral agent. It derives from an abacavir.